View source for Northwestern University patent applications published on September 12th, 2024

'''Summary of the patent applications from Northwestern University on September 12th, 2024'''

1. **Summary**:
Northwestern University has recently filed patents for innovative technologies including a wavelength converter with pixel arrays, antisense polynucleotides for treating muscular dystrophy, lipophilic membrane dye constructs for targeted drug delivery to brain tumors, and artificial melanin material for skin healing. These patents showcase advancements in diverse fields such as optics, genetics, drug delivery, and dermatology.

2. **Key Points of Patents**:
* Wavelength converter with pixel arrays for efficient light conversion.
* Antisense polynucleotides targeting the γ-sarcoglycan gene for muscular dystrophy treatment.
* Lipophilic membrane dye constructs for targeted drug delivery to brain tumors.
* Artificial melanin material for accelerated skin healing.

3. **Notable Applications**:
* Enhanced visibility and control in optical communication systems.
* Targeted therapy for muscular dystrophy with potential improvement in muscle function.
* Improved treatment efficacy and reduced side effects in brain tumor therapies.
* Faster and more effective skin healing with reduced scarring and enhanced cosmetic outcomes.




==Patent applications for Northwestern University on September 12th, 2024==

===SYSTEM AND METHOD FOR DETECTING AN EMOTIONAL STATE ([[Northwestern University (18597748). SYSTEM AND METHOD FOR DETECTING AN EMOTIONAL STATE simplified abstract|18597748]])===


'''Main Inventor'''

Jeffrey S. Burgdorf


===MELANIN MATERIALS FOR TISSUE REPAIR ([[Northwestern University (18288473). MELANIN MATERIALS FOR TISSUE REPAIR simplified abstract|18288473]])===


'''Main Inventor'''

Nathan C. GIANNESCHI


===TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION ([[Northwestern University (18432829). TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION simplified abstract|18432829]])===


'''Main Inventor'''

Thomas A. MUSTOE


===INDOCARBOCYANINE LIPID DERIVATIVES FOR IN VIVO CARGO DELIVERY ([[Northwestern University (18572447). INDOCARBOCYANINE LIPID DERIVATIVES FOR IN VIVO CARGO DELIVERY simplified abstract|18572447]])===


'''Main Inventor'''

Dmitri Simberg


===COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING ([[Northwestern University (18659737). COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING simplified abstract|18659737]])===


'''Main Inventor'''

Elizabeth McNally


===WAVELENGTH CONVERTING NATURAL VISION SYSTEM ([[Northwestern University (18272735). WAVELENGTH CONVERTING NATURAL VISION SYSTEM simplified abstract|18272735]])===


'''Main Inventor'''

Hooman Mohseni